Parallel

Parallel is an innovative company focused on providing advanced AI solutions to streamline healthcare administration, primarily in medical coding, enhancing operational efficiency for healthcare providers. Founded in 2024 by Paul Lafforgue, Christopher Rydahl and Thomas Sohet in Paris, France, Parallel specializes in AI-driven healthcare administration solutions. The firm successfully completed its first deal on April 3, 2025. In its Seed round, Parallel raised EUR 3.

20 mn, led by Frst Capital and joined by Better Angle, Bpifrance Investissement, Kima Ventures, and Y Combinator. The company was founded by individuals with prior entrepreneurial experience, although specific details are not provided. Parallel offers a suite of advanced AI solutions designed to alleviate the administrative burdens faced by healthcare providers, with a primary focus on medical coding. Their flagship product, the coding agent, operates alongside hospital teams to enhance the accuracy and speed of medical coding by leveraging Generative AI to interpret unstructured data and patient contexts.

This product is tailored to meet specific coding standards and hospital rules, ensuring that diagnoses are both precise and compliant. The integration of this solution into existing systems is facilitated through remote VPN access and Robotic Process Automation, which mimics human operation while ensuring secure deployment without imposing an integration burden. The company primarily serves hospitals within the European Union, as indicated by its compliance with RGPD, HDS, and ISO 27001 standards, aiming to improve operational efficiency and optimize revenue generation through automated and accurate coding solutions. Parallel generates revenue through business-to-business partnerships with healthcare institutions, particularly hospitals.

The company's transaction structure is based on a subscription model, where clients pay for access to the coding agent and other AI tools. These subscriptions vary based on the scale of deployment, with pricing tiers reflecting the complexity of services utilized. The coding agent provides automated coding for simpler cases and intelligent suggestions for more complex scenarios, enhancing value for healthcare providers. By aligning services with operational needs, Parallel facilitates a streamlined billing process that correlates directly with efficiency and accuracy improvements realized by hospitals.

In March 2026, Parallel raised EUR 17. 3 million in series A funding led by Index Ventures, with participation from Hexa, Frst Ventures, Y Combinator, and individual investors. The company will use the March 2026 funding to expand its artificial intelligence-powered medical coding solutions, support international growth, and develop additional artificial intelligence agents for hospital administrative workflows.